Fifty-eight per cent of people taking or considering taking GLP-1 drugs said weight loss was their main driver, while 42 per cent said diabetes was their primary reason
Publisher Responsibility: The publisher of this article is not affiliated with altRx, Trinity Healthcare Supply LLC, CareGLP, CareValidate Health, Usable Health PC, or any partner pharmacy
Regeneron materials described in this manuscript, or comparable alternatives, may be available to academic researchers upon request through our portal: under a material transfer agreement
This retatrutide peptide is engineered to act on three major signaling systems: GIP, GLP-1, and glucagon
Dosing accuracy with compounded injectables requires careful adherence to clinician and pharmacy instructions
To prevent type 2 diabetes, people should reach and maintain healthy body weight, engage in at least 150 minutes of moderate exercise each week, eat a healthy diet avoiding sugar and saturated fats, and not smoke tobacco
